What a peptide actually is

A peptide is a short chain of amino acids. That is the whole definition. Chain them longer and the same molecule gets called a protein; the boundary is a convention, not a biological event, and it sits somewhere around fifty amino acids depending on who is writing.

So peptide is a statement about size, not about what something does. Insulin is a peptide. So is the collagen fragment in a face cream. They have almost nothing else in common, and any sentence that begins "peptides do…" is already wrong.

Why the word causes so much trouble

Because it gets used as if it were a category of effect. It is not. Two peptides can be the same length and act on entirely unrelated systems — one signalling to a receptor in the gut, another never touching a receptor at all.

The useful question is never "what do peptides do". It is: which molecule, at what dose, in what form, and what is the evidence for that specific one. Four questions, and they have to be asked separately every time.

Signal and substrate

One distinction is worth carrying, because it explains a lot of otherwise confusing marketing. Some molecules are signals — they bind something and ask the body to change what it is doing. Others are substrate — raw material delivered to a process that is already running.

A signal needs a working receptor and an intact downstream pathway to matter. A substrate does not. Neither approach is inherently better; they answer different questions, and a protocol built entirely from one is usually a protocol built by someone who only knows one.

Format changes more than people expect

The same molecule arrives in very different shapes. Lyophilized — freeze-dried — sits stable on a shelf and has to be reconstituted before use. Pre-filled pens skip that step entirely. The molecule is identical; what changes is who does the work, what can go wrong, and how it has to be stored.

For a clinic, that is an operational decision, not a scientific one. For a patient, it is mostly invisible until something is stored wrong.

What we will not tell you

We supply material to licensed clinical operators. We do not decide what belongs in your protocol, and we are not the right people to ask whether a given molecule is appropriate for a given person — that is a conversation with a clinician who can see the whole picture, including everything else you are taking.

What we can put in your hands is documentation: what the material is, how it was made, and what testing it passed. That is a narrower promise than most of this industry makes, and it is one we can keep.